REVVITY, INC Restricted Cash, Current
REVVITY, INC (RVTY) had Restricted Cash, Current of $713.00 thousand as of 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-11
- 2026-07-05: Restricted Cash, Current $713.00K.
- 2026-04-05: Restricted Cash, Current $428.00K.
- 2025-12-28: Restricted Cash, Current $6.00K.
- 2025-09-28: Restricted Cash, Current $1.19M.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-07-05 | $713.00K 10-Q · filed 2026-08-11 |
| 2026-04-05 | $428.00K 10-Q · filed 2026-05-12 |
| 2025-12-28 | $6.00K 10-K · filed 2026-02-24 |
| 2025-09-28 | $1.19M 10-Q · filed 2025-11-04 |
| 2025-06-29 | $1.14M 10-Q · filed 2026-08-11 |
| 2025-03-30 | $1.07M 10-Q · filed 2026-05-12 |
| 2024-12-29 | $1.06M 10-K · filed 2026-02-24 |
| 2024-09-29 | $1.03M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $1.31M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $1.38M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $1.21M 10-K · filed 2026-02-24 |
| 2023-10-01 | $1.24M 10-Q · filed 2024-11-06 |
| 2023-07-02 | $1.06M 10-Q · filed 2024-08-06 |
| 2023-04-02 | $1.02M 10-Q · filed 2024-05-07 |
| 2023-01-01 | $1.04M 10-K · filed 2025-02-25 |
| 2022-10-02 | $284.00K 10-Q · filed 2023-11-07 |
| 2022-07-03 | $1.07M 10-Q · filed 2023-08-09 |
| 2022-04-03 | $997.00K 10-Q · filed 2023-05-12 |
| 2022-01-02 | $1.02M 10-K · filed 2024-02-27 |
| 2021-10-03 | $1.69M 10-Q · filed 2022-11-14 |
| 2021-07-04 | $1.75M 10-Q · filed 2022-08-09 |
| 2021-04-04 | $2.17M 10-Q · filed 2022-05-10 |
| 2021-01-03 | $578.00K 10-K · filed 2023-03-01 |
| 2020-10-04 | $110.00K 10-Q · filed 2021-11-09 |
| 2020-07-05 | $1.41M 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |